Phase Five Communications is a full-service medical education company that excels in mining raw data and creating strategic scientific communications to drive brand key messages. The company’s approach to building Scientific Platforms is the industry model for establishing and advancing a product’s value proposition. An organized, central repository of evidence-based messaging, the Scientific Platform guides communications across disciplines; it’s a methodical process that, at Phase Five, is anything but static. In a world of generic thinking, Phase Five’s Scientific Platforms are the foundation for the preclinical, clinical and pharmaco-economic stories that drive differentiation and reimbursement.
Phase Five is a leader in digital platforms and content, delivering constructive, approvable cross-discipline communications in highly targeted surround-sound. Because engaging physicians in contexts that align with their clinical needs, online behaviors and channel preferences is more critical than ever, the company continues to push for more effective vehicles and unexpected ways to use new media.
Phase Five is part of New York–based ghg | greyhealth group and its holding company, WPP.